Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Proceedings of the 2017 ISEV symposium on "HIV, NeuroHIV, drug abuse, & EVs".

Hu G, Yelamanchili S, Kashanchi F, Haughey N, Bond VC, Witwer KW, Pulliam L, Buch S.

J Neurovirol. 2017 Dec;23(6):935-940. doi: 10.1007/s13365-017-0599-8. Epub 2017 Nov 16.

PMID:
29147885
2.

Proceedings of the ISEV symposium on "HIV, NeuroAIDS, drug abuse & EVs".

Hu G, Witwer KW, Bond VC, Haughey N, Kashanchi F, Pulliam L, Buch S.

J Extracell Vesicles. 2017 Mar 10;6(1):1294360. doi: 10.1080/20013078.2017.1294360. eCollection 2017.

3.

Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.

Huang MB, Gonzalez RR, Lillard J, Bond VC.

Oncotarget. 2017 Feb 14;8(7):11302-11315. doi: 10.18632/oncotarget.14513.

4.

Adipose-Derived Stem Cells Induce Angiogenesis via Microvesicle Transport of miRNA-31.

Kang T, Jones TM, Naddell C, Bacanamwo M, Calvert JW, Thompson WE, Bond VC, Chen YE, Liu D.

Stem Cells Transl Med. 2016 Apr;5(4):440-50. doi: 10.5966/sctm.2015-0177. Epub 2016 Mar 1.

5.

Micro RNA in Exosomes from HIV-Infected Macrophages.

Roth WW, Huang MB, Addae Konadu K, Powell MD, Bond VC.

Int J Environ Res Public Health. 2015 Dec 22;13(1):ijerph13010032. doi: 10.3390/ijerph13010032.

6.

Characterizing the HIV/AIDS Epidemic in the United States and China.

Huang MB, Ye L, Liang BY, Ning CY, Roth WW, Jiang JJ, Huang JG, Zhou B, Zang N, Powell MD, Liang H, Bond VC.

Int J Environ Res Public Health. 2015 Dec 22;13(1):ijerph13010030. doi: 10.3390/ijerph13010030.

7.

Hallmarks of HIV-1 pathogenesis are modulated by Nef's Secretion Modification Region.

Konadu KA, Anderson JS, Huang MB, Ali SA, Powell MD, Villinger F, Bond VC.

J AIDS Clin Res. 2015 Jul;6(7). pii: 476. Epub 2015 Jun 30.

8.

Nef exosomes isolated from the plasma of individuals with HIV-associated dementia (HAD) can induce Aβ(1-42) secretion in SH-SY5Y neural cells.

Khan MB, Lang MJ, Huang MB, Raymond A, Bond VC, Shiramizu B, Powell MD.

J Neurovirol. 2016 Apr;22(2):179-90. doi: 10.1007/s13365-015-0383-6. Epub 2015 Sep 25.

9.

Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.

Katkoori VR, Basson MD, Bond VC, Manne U, Bumpers HL.

Oncotarget. 2015 Sep 29;6(29):27763-77. doi: 10.18632/oncotarget.4615.

10.

Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase.

Cox BD, Prosser AR, Sun Y, Li Z, Lee S, Huang MB, Bond VC, Snyder JP, Krystal M, Wilson LJ, Liotta DC.

ACS Med Chem Lett. 2015 May 6;6(7):753-7. doi: 10.1021/acsmedchemlett.5b00036. eCollection 2015 Jul 9.

11.

Association of Cytokines With Exosomes in the Plasma of HIV-1-Seropositive Individuals.

Konadu KA, Chu J, Huang MB, Amancha PK, Armstrong W, Powell MD, Villinger F, Bond VC.

J Infect Dis. 2015 Jun 1;211(11):1712-6. doi: 10.1093/infdis/jiu676. Epub 2014 Dec 15.

12.

Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation.

Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, Bond VC, Borràs FE, Breakefield X, Budnik V, Buzas E, Camussi G, Clayton A, Cocucci E, Falcon-Perez JM, Gabrielsson S, Gho YS, Gupta D, Harsha HC, Hendrix A, Hill AF, Inal JM, Jenster G, Krämer-Albers EM, Lim SK, Llorente A, Lötvall J, Marcilla A, Mincheva-Nilsson L, Nazarenko I, Nieuwland R, Nolte-'t Hoen EN, Pandey A, Patel T, Piper MG, Pluchino S, Prasad TS, Rajendran L, Raposo G, Record M, Reid GE, Sánchez-Madrid F, Schiffelers RM, Siljander P, Stensballe A, Stoorvogel W, Taylor D, Thery C, Valadi H, van Balkom BW, Vázquez J, Vidal M, Wauben MH, Yáñez-Mó M, Zoeller M, Mathivanan S.

PLoS Biol. 2012;10(12):e1001450. doi: 10.1371/journal.pbio.1001450. Epub 2012 Dec 18.

13.

High-resolution whole-genome haplotyping using limited seed data.

Rao W, Ma Y, Ma L, Zhao J, Li Q, Gu W, Zhang K, Bond VC, Song Q.

Nat Methods. 2013 Jan;10(1):6-7. doi: 10.1038/nmeth.2308. No abstract available.

14.

Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling.

Campbell PE, Isayev O, Ali SA, Roth WW, Huang MB, Powell MD, Leszczynski J, Bond VC.

J Mol Model. 2012 Oct;18(10):4603-13. doi: 10.1007/s00894-012-1452-x. Epub 2012 May 30.

15.

Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Shelton MN, Huang MB, Ali SA, Powell MD, Bond VC.

J Virol. 2012 Jan;86(1):406-19. doi: 10.1128/JVI.05720-11. Epub 2011 Oct 19.

16.

When less is heard than meets the ear: change deafness in a telephone conversation.

Fenn KM, Shintel H, Atkins AS, Skipper JI, Bond VC, Nusbaum HC.

Q J Exp Psychol (Hove). 2011 Jul;64(7):1442-56. doi: 10.1080/17470218.2011.570353.

PMID:
21604232
17.

Plasmodium berghei ANKA infection increases Foxp3, IL-10 and IL-2 in CXCL-10 deficient C57BL/6 mice.

Sarfo BY, Wilson NO, Bond VC, Stiles JK.

Malar J. 2011 Mar 28;10:69. doi: 10.1186/1475-2875-10-69.

18.

HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals.

Raymond AD, Campbell-Sims TC, Khan M, Lang M, Huang MB, Bond VC, Powell MD.

AIDS Res Hum Retroviruses. 2011 Feb;27(2):167-78. doi: 10.1089/aid.2009.0170. Epub 2010 Oct 21.

19.

Genetic characterization of HIV type 1 Nef-induced vesicle secretion.

Ali SA, Huang MB, Campbell PE, Roth WW, Campbell T, Khan M, Newman G, Villinger F, Powell MD, Bond VC.

AIDS Res Hum Retroviruses. 2010 Feb;26(2):173-92. doi: 10.1089/aid.2009.0068.

20.

Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization.

Sengupta N, Afzal A, Caballero S, Chang KH, Shaw LC, Pang JJ, Bond VC, Bhutto I, Baba T, Lutty GA, Grant MB.

Invest Ophthalmol Vis Sci. 2010 May;51(5):2697-704. doi: 10.1167/iovs.09-4137. Epub 2009 Dec 10.

Supplemental Content

Support Center